Insider Shareholders with Direct Ownership of Athira Pharma, Inc. (ATHA)
This section provides a comprehensive overview of the insiders with direct ownership of Athira Pharma, Inc. (ATHA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Athira Pharma, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Glenna Mileson
Chief Financial Officer |
80,579 | 2,614 | 159,930 $68,769 | 10 |
Dec 28, 2022
Added 23.82%
|
|
Mark James Litton
President and CEO |
113,611 | 17,812 | 159,365 $68,526 | 11 |
Sep 05, 2024
Reduced 3.06%
|
| 30,003 | 0 | 144,884 $62,300 | 2 |
Jun 15, 2021
Added 0.69%
|
|
|
Andrew Gengos
CFO and Chief Business Officer |
100,012 | 2,480 | 97,532 $41,938 | 8 |
Sep 05, 2024
Reduced 1.29%
|
|
Kevin Church
CHIEF SCIENTIFIC OFFICER |
59,069 | 7,551 | 92,684 $39,854 | 17 |
Sep 05, 2024
Reduced 2.65%
|
|
Hans Moebius
Chief Medical Officer |
91,482 | 0 | 91,482 $39,337 | 11 |
Jan 04, 2024
Added 9.85%
|
| 80,400 | 0 | 80,715 $34,707 | 4 |
Jun 24, 2024
Added 25.34%
|
|
|
Mark Worthington
General Counsel and CCO |
51,163 | 7,551 | 51,927 $22,328 | 9 |
Sep 05, 2024
Reduced 4.64%
|
| 25,000 | 0 | 25,783 $11,086 | 2 |
Mar 30, 2023
Added 36.78%
|
|
|
Rachel Lenington
COO and CDO |
30,000 | 9,130 | 20,870 $8,974 | 6 |
Sep 05, 2024
Reduced 10.79%
|
| 5,000 | 0 | 5,000 $2,150 | 1 |
Mar 29, 2023
Added 50.0%
|